OmniSonics Medical Technologies, Inc. is a privately held company. The company's investors include:
Canaan Partners (www.canaanpartners.com) is a private investment firm that provides capital and guidance to entrepreneurial ventures looking to become world-class companies.
Domain Associates (www.domainvc.com) concentrates on life sciences and invests in companies focused on medical devices and instrumentation, diagnostics, healthcare information and biopharmaceuticals.
GEAM (www.geam.com), the investment arm of General Electric, covers a variety of industries including medical technology and all stages of development, with a focus on mid- to late-stage growth opportunities.
Hambrecht & Quist Capital Management (www.hqcm.com) provides private equity funding worldwide. Its life sciences sector focuses on medical devices in large therapeutic markets, biopharmaceutical drugs, genomics and nanotechnology.
Johnson & Johnson Development Group (www.jnj.com), a division of Johnson & Johnson, provides funding for companies with innovative devices and therapies, biotechnology products, and advanced pharmaceuticals.
Mitsubishi International Corporation (MIC) (www.micusa.com), a subsidiary of Mitsubishi Corporation, conducts transactions in a range of businesses including chemicals, information technology, energy, metals, machinery and living essentials.
New England Partners (www.nepartners.com), a Boston-based private equity investment firm, specializes in healthcare (including life sciences and devices), technology and consumer products.
Nomura Phase4 Ventures ("NPV") (www.nomura.com/npv), a division of Nomura International plc, is part of The Nomura Group, and invests in emerging healthcare industries (biopharma, specialty pharmaceuticals and medical devices).
Phoenix Life Insurance Company (www.phoenixwm.com), part of The Phoenix Companies, Inc. (PNX), is a leading provider of wealth management products and services to individuals and institutions.
Prism VentureWorks (www.prismventure.com), a venture capital firm that has funded more than 50 start-up, early-stage and growth companies in healthcare technology, business infrastructure software and communications.
